Roser Zabala - Laboratorio Reig Chief Officer

All Insiders . Spain . 
Stock . Laboratorio Reig Jofre . Stakeholders . Insider . Roser Zabala
RJF Stock  EUR 2.82  0.01  0.35%   

Insider

Roser Zabala is Chief Officer of Laboratorio Reig Jofre
Phone34 93 480 67 10
Webhttps://www.reigjofre.com

Laboratorio Reig Management Efficiency

The company has return on total asset (ROA) of 0.0165 % which means that it generated a profit of $0.0165 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0223 %, meaning that it generated $0.0223 on every $100 dollars invested by stockholders. Laboratorio Reig's management efficiency ratios could be used to measure how well Laboratorio Reig manages its routine affairs as well as how well it operates its assets and liabilities.
Laboratorio Reig Jofre has accumulated 34.67 M in total debt with debt to equity ratio (D/E) of 22.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Laboratorio Reig Jofre has a current ratio of 2.28, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Laboratorio Reig until it has trouble settling it off, either with new capital or with free cash flow. So, Laboratorio Reig's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Laboratorio Reig Jofre sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Laboratorio to invest in growth at high rates of return. When we think about Laboratorio Reig's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Ignacio ToledanoLaboratorios Farmaceuticos ROVI
N/A
Francisco GarcaLaboratorios Farmaceuticos ROVI
N/A
Jos MartinezLosaPharma Mar SA
N/A
Volker KoscielnyAlmirall SA
N/A
Xavier RiberaOryzon Genomics SA
N/A
Juan CarreteroPharma Mar SA
74
Carlos PiquAlmirall SA
51
Ana LimonOryzon Genomics SA
N/A
Mara CaballeroPharma Mar SA
N/A
Karl ZiegelbauerAlmirall SA
N/A
Jose SousaFaroPharma Mar SA
N/A
Michael RopackiOryzon Genomics SA
N/A
Francesca WuttkeAlmirall SA
N/A
Marcos PintoLaboratorios Farmaceuticos ROVI
N/A
Pablo AlvarezAlmirall SA
N/A
Mercedes SnchezLaboratorios Farmaceuticos ROVI
N/A
Jordi PeyOryzon Genomics SA
N/A
Fatima GarciaLaboratorios Farmaceuticos ROVI
N/A
Neus BernadoOryzon Genomics SA
N/A
Rosario PrezLaboratorios Farmaceuticos ROVI
N/A
Mercedes SanchezLaboratorios Farmaceuticos ROVI
N/A
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and nutritional supplements. Laboratorio Reig Jofre, S.A. was founded in 1929 and is based in Barcelona, Spain. LABORATORIO REIG operates under Drug Manufacturers - Specialty Generic classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1000 people. Laboratorio Reig Jofre (RJF) is traded on Madrid Exchange in Spain and employs 1,196 people.

Management Performance

Return On Equity0.0223
Return On Asset0.0165

Laboratorio Reig Jofre Leadership Team

Elected by the shareholders, the Laboratorio Reig's board of directors comprises two types of representatives: Laboratorio Reig inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Laboratorio. The board's role is to monitor Laboratorio Reig's management team and ensure that shareholders' interests are well served. Laboratorio Reig's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Laboratorio Reig's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nuria Molas, Head Network
Alejandro Reig, VP Mang
Victoria Serra, Ma HR
Antonio Gomez, Managing Spain
Marc Ramos, Head Consolidation
Inma SantaPau, Head Relations
Ignasi Reig, CEO Director
Estefana Ruiz, Group Controller
Roser Zabala, Chief Officer
Ignacio Rocafort, Chief GM

Laboratorio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Laboratorio Reig a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0223
Return On Asset0.0165
Profit Margin0.02 %
Operating Margin0.03 %
Current Valuation245.01 M
Shares Outstanding76.7 M
Shares Owned By Insiders77.64 %
Shares Owned By Institutions3.46 %
Price To Earning16.69 X
Price To Book0.99 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Other Information on Investing in Laboratorio Stock

Laboratorio Reig financial ratios help investors to determine whether Laboratorio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorio with respect to the benefits of owning Laboratorio Reig security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY